Dimension Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 21, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $65,000,000
Company Info
- Founding Year
- 2013
- Founders
- Annalisa Jenkins
- Company Description
- Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. The company is focused on building its adeno-associated virus (AAV) therapeutic capabilities and advancing multiple gene therapy programs in rare diseases through partnerships with REGENX Biosciences and the University of Pennsylvania.
- Market
- Gene Therapy for Rare Diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Jennison Associates, New Leaf Venture Partners, OrbiMed Advisors, Partner Fund Management, RA Capital, Rock Springs Capital, Tourbillon Global Ventures